Leucylleucine methyl ester
Based on 21 publication(s) in Google Scholar
Leucylleucine methyl ester is a lysosomotropic agent that can be used to eliminate gamma delta T cells in human peripheral blood.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 13022-42-9
- Formule: C13H26N2O3
- Masse moléculaire:258.36
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Leucylleucine methyl ester
More- Cell Res. 2026 Jan;36(1):51-71. [Abstract]
- Autophagy. 2024 Dec;20(12):2697-2718. [Abstract]
- Adv Sci (Weinh). 2026 May;13(25):e21681. [Abstract]
- Biomaterials. 2026 Jun 27:335:124405. [Abstract]
- Biomaterials. 2025 Jun:317:123091. [Abstract]
- Environ Chem Ecotoxicol. 2025 Nov 19;8:267-280.
- J Neuroinflammation. 2025 Oct 29;22(1):252. [Abstract]
- EMBO J. 2025 May;44(9):2596-2619. [Abstract]
- World J Gastroenterol. 2026 Feb 28;32(8):113299. [Abstract]
- J Cell Biol. 2025 Nov 3;224(11):e202404018. [Abstract]
- PLoS Pathog. 2025 Sep 16;21(9):e1013513. [Abstract]
- PLoS Pathog. 2024 Feb 14;20(2):e1011981. [Abstract]
- Toxicol Appl Pharmacol. 2026 Jan:506:117632. [Abstract]
- Int Immunol. 2021 Aug 23;33(9):491-504. [Abstract]
- FEBS Lett. 2026 Apr 24. [Abstract]
- Traffic. 2022 May;23(5):238-269. [Abstract]
- bioRxiv. 2026 Apr 21.
- SSRN. 2025 Aug 13.
- Preprints. 2025 Jul 8.
- bioRxiv. 2024 July 07.
- bioRxiv. 2024 Mar 13:2024.03.12.584718. [Abstract]
-
IP
-
IF
-
Cell Imaging/Staining
-
IP
-
IP
Activité biologique
Chemical Information
-
CAS No. 13022-42-9
-
Masse moléculaire 258.36
-
Formule C13H26N2O3
-
SMILES
CC(C)C[C@H](N)C(N[C@@H](CC(C)C)C(OC)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (21)
-
Journal Impact Factor
-
Most Recent
-
Cell Res
2026 Jan;36(1):51-71. PMID: 41478856 -
Autophagy
2024 Dec;20(12):2697-2718. PMID: 39081059 -
Adv Sci (Weinh)
Loss of VMP1 Impairs Tight Junction Recycling and Aggravates Intestinal Barrier Dysfunction in Inflammatory Bowel Disease. [Abstract]2026 May;13(25):e21681. PMID: 41757559 -
Biomaterials
In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization. [Abstract]2026 Jun 27:335:124405. PMID: 42372507 -
Biomaterials
Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting. [Abstract]2025 Jun:317:123091. PMID: 39778270 -
-
J Neuroinflammation
Immune subversion by Leishmania infantum parasites suppresses NLRP3-driven inflammatory responses in amyloid-β-activated microglia. [Abstract]2025 Oct 29;22(1):252. PMID: 41162989 -
EMBO J
S-palmitoylation modulates ATG2-dependent non-vesicular lipid transport during starvation-induced autophagy. [Abstract]2025 May;44(9):2596-2619. PMID: 40128367
Leucylleucine methyl ester purchased from MedChemExpress. Usage Cited in: EMBO J. 2025 May;44(9):2596-2619. [Abstract]
S-palmitoylation of HA-ATG2A detected by ABE assay in HEK293T cells treated with 1 mM LLOMe for indicated times.
-
World J Gastroenterol
Wogonin derivative V8 enhances bortezomib efficacy in gastric carcinoma by disrupting lysosome-mediated drug resistance. [Abstract]2026 Feb 28;32(8):113299. PMID: 41809875 -
J Cell Biol
JIP4 and RILPL1 utilize opposing motor force to dynamically regulate lysosomal tubulation. [Abstract]2025 Nov 3;224(11):e202404018. PMID: 40990465
Leucylleucine methyl ester purchased from MedChemExpress. Usage Cited in: J Cell Biol. 2025 Nov 3;224(11):e202404018. [Abstract]
U2OS cells were transfected with HaloTag-LRRK2 for 36 h. Cells were then treated with DMSO, LLOME (1 mM), or LLOME+MLi2 for 2 h before fixation. Cells were then stained for RILPL1 and LAMP2.
Leucylleucine methyl ester purchased from MedChemExpress. Usage Cited in: J Cell Biol. 2025 Nov 3;224(11):e202404018. [Abstract]
Quantification of the RILPL1 lysosomes per cell. Cells were treated with DMSO, LLOME (1 mM), or LLOME+MLi2 for 2 h.
Leucylleucine methyl ester purchased from MedChemExpress. Usage Cited in: J Cell Biol. 2025 Nov 3;224(11):e202404018. [Abstract]
HEK293FT cells were transfected with 3xflag-LRRK2 and mCherry-RILPL1 for 24 h. Cells were treated or not with LLOME (1 mM) for 2 h, and lysates were subjected to immunoprecipitation with anti-RFP antibodies. RFP, LRRK2, and pT73-RAB10 were blotted.
Leucylleucine methyl ester purchased from MedChemExpress. Usage Cited in: J Cell Biol. 2025 Nov 3;224(11):e202404018. [Abstract]
HEK293T cells stably expressing GFP-LRRK2 and TMEM192-3xHA were seeded and treated with DMSO, LLOME (1 mM), or LLOME + MLi2 24 h later. Lysosomes were purified with anti-HA beads following the LYSO-IP technique. Lysosomes were then lysed, and their content was analyzed via immunoblotting.
-
PLoS Pathog
A non-canonical activation of the host's ESCRT machinery is required for the scission of parasitophorous vacuoles and the replication of Leishmania donovani. [Abstract]2025 Sep 16;21(9):e1013513. PMID: 40956840 -
PLoS Pathog
The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization. [Abstract]2024 Feb 14;20(2):e1011981. PMID: 38354122 -
Toxicol Appl Pharmacol
Honokiol ameliorates hepatic fibrosis by inducing lysosomal membrane permeabilization and impairing lipophagy in hepatic stellate cells. [Abstract]2026 Jan:506:117632. PMID: 41207513 -
Int Immunol
Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1. [Abstract]2021 Aug 23;33(9):491-504. PMID: 34297096 -
FEBS Lett
2026 Apr 24. PMID: 42032884 -
Traffic
2022 May;23(5):238-269. PMID: 35343629 -
-
-
-
-
bioRxiv
Autophagosome turnover requires Arp2/3 complex-mediated maintenance of lysosomal integrity. [Abstract]2024 Mar 13:2024.03.12.584718. PMID: 38559247
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)